{"entity":{"type":"insider","cik":"0001571820","url":"/insider/0001571820","json_url":"/insider/0001571820.json","name":"Chanda Sanjay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2014-09-12","last":"2026-01-07","span_basis":"filed_date"},"name_variants":[{"name":"Chanda Sanjay","source":"filing","n_filings":5,"first_seen":"2014-09-12","last_seen":"2026-01-07"}],"transactions":[{"id":6035772,"accession":"0001193125-26-006765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-006765","line_url":"/filing/0001193125-26-006765#line-2","is_derivative":false,"issuer_cik":"0001571820","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001571820","owner_cik":"0001571820","owner_name":"Chanda Sanjay","owner_display_name":"Chanda Sanjay","owner_url":"/insider/0001571820","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5956.0,"shares_display":"5,956","price_per_share":1.012,"price_display":"1.01","price_state":"stated","total_value":6027.472,"total_display":"6,027.47","total_whole":"6,027","shares_owned_after":75823.0,"shares_owned_after_display":"75,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-07","scope":"insider"},{"id":6035769,"accession":"0001193125-26-006765","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-006765","line_url":"/filing/0001193125-26-006765#line-1","is_derivative":false,"issuer_cik":"0001571820","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001571820","owner_cik":"0001571820","owner_name":"Chanda Sanjay","owner_display_name":"Chanda Sanjay","owner_url":"/insider/0001571820","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3295.0,"shares_display":"3,295","price_per_share":1.003,"price_display":"1.00","price_state":"stated","total_value":3304.885,"total_display":"3,304.88","total_whole":"3,305","shares_owned_after":81779.0,"shares_owned_after_display":"81,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":5116290,"accession":"0000950170-25-003157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-003157","line_url":"/filing/0000950170-25-003157#line-1","is_derivative":false,"issuer_cik":"0001571820","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001571820","owner_cik":"0001571820","owner_name":"Chanda Sanjay","owner_display_name":"Chanda Sanjay","owner_url":"/insider/0001571820","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2957.0,"shares_display":"2,957","price_per_share":1.341,"price_display":"1.34","price_state":"stated","total_value":3965.337,"total_display":"3,965.34","total_whole":"3,965","shares_owned_after":29824.0,"shares_owned_after_display":"29,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":8597957,"accession":"0001209191-15-022578","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-022578","line_url":"/filing/0001209191-15-022578","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001571820","owner_name":"Chanda Sanjay","owner_display_name":"Chanda Sanjay","owner_url":"/insider/0001571820","role":"Officer (SVP, Drug Development)","role_mark":"O","role_mark_label":"Officer (SVP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":29087.0,"shares_owned_after_display":"29,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-04","scope":"insider","n_lines":2},{"id":6709784,"accession":"0001209191-14-072053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-072053","line_url":"/filing/0001209191-14-072053#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001571820","owner_name":"Chanda Sanjay","owner_display_name":"Chanda Sanjay","owner_url":"/insider/0001571820","role":"Officer (SVP, Drug Development)","role_mark":"O","role_mark_label":"Officer (SVP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":175000.0,"total_display":"175,000.00","total_whole":"175,000","shares_owned_after":3995.0,"shares_owned_after_display":"3,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-12-01","scope":"insider"},{"id":7001232,"accession":"0001209191-14-057715","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-057715","line_url":"/filing/0001209191-14-057715","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001571820","owner_name":"Chanda Sanjay","owner_display_name":"Chanda Sanjay","owner_url":"/insider/0001571820","role":"Officer (SVP, Drug Development)","role_mark":"O","role_mark_label":"Officer (SVP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.25,"price_display":"24.25","price_state":"stated","total_value":242500.0,"total_display":"242,500.00","total_whole":"242,500","shares_owned_after":3995.0,"shares_owned_after_display":"3,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-10","filed_date":"2014-09-12","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001880438","name":"AN2 Therapeutics, Inc.","url":"/issuer/0001880438","role":"Officer (Chief Development Officer)","n_filings":2,"first_seen":"2025-01-07","last_seen":"2026-01-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Officer (SVP, Drug Development)","n_filings":3,"first_seen":"2014-09-12","last_seen":"2015-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001571820","retrieved_at":"2026-08-24T00:01:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}